ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert …

WS Aronow, JL Fleg, CJ Pepine, NT Artinian, G Bakris… - Circulation, 2011 - Am Heart Assoc
This document was written with the intent to be a complete reference at the time of
publication on the topic of managing hypertension in the elderly. Given the length of the …

Biomarkers of cardiovascular disease: molecular basis and practical considerations

RS Vasan - Circulation, 2006 - Am Heart Assoc
echocardiogram) may be expected to facilitate the identification of patients with chest pain of
an ischemic etiology (angina). In a patient presenting to the emergency department with …

Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension

MC Brandt, F Mahfoud, S Reda, SH Schirmer… - Journal of the American …, 2012 - jacc.org
Objectives: This study investigated the effect of catheter-based renal sympathetic
denervation (RD) on left ventricular hypertrophy (LVH) and systolic and diastolic function in …

Prognostic significance of left ventricular mass change during treatment of hypertension

RB Devereux, K Wachtell, E Gerdts, K Boman… - Jama, 2004 - jamanetwork.com
ContextIncreased baseline left ventricular (LV) mass predicts cardiovascular (CV)
complications of hypertension, but the relation between lower LV mass and outcome during …

Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies

C Cuspidi, C Sala, F Negri, G Mancia… - Journal of human …, 2012 - nature.com
Left-ventricular hypertrophy (LVH) is a cardinal manifestation of hypertensive organ damage
associated with an increased cardiovascular (CV) risk. We reviewed recent literature on the …

LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice

AC Armstrong, S Gidding, O Gjesdal, C Wu… - JACC: Cardiovascular …, 2012 - jacc.org
The authors investigated 3 important areas related to the clinical use of left ventricular mass
(LVM): accuracy of assessments by echocardiography and cardiac magnetic resonance …

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction …

K Wachtell, M Lehto, E Gerdts, MH Olsen… - Journal of the American …, 2005 - jacc.org
Objectives: This study was designed to evaluate whether different antihypertensive
treatment regimens with similar blood pressure reduction have different effects on new-onset …

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E–left ventricular hypertrophy …

B Pitt, N Reichek, R Willenbrock, F Zannad… - Circulation, 2003 - Am Heart Assoc
Background—Elevated renin-angiotensin-aldosterone system activity correlates with left
ventricular hypertrophy (LVH) and cardiovascular risk, but the relative contributions of …

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) …

RB Devereux, B Dahlöf, E Gerdts, K Boman… - Circulation, 2004 - Am Heart Assoc
Background—An echocardiographic substudy of the Losartan Intervention for Endpoint
Reduction in Hypertension (LIFE) trial was designed to test the ability of losartan to reduce …

Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?

M Foppa, BB Duncan, LEP Rohde - Cardiovascular ultrasound, 2005 - Springer
Left ventricular hypertrophy is an important risk factor in cardiovascular disease and
echocardiography has been widely used for diagnosis. Although an adequate methodologic …